Conferences series summons the world's leading diabeticians, endocrinologists, surgeons, physicians, scientists and scholars to the “31st International Diabetes and Healthcare conference” on November 17-18, 2022 London, UK. This leading conference inspires the recent improvements related to diabetes, the main aim of this conference is sharing the knowledge of expertise in the respective field to the upcoming scholars and researchers to increase their knowledge related to diabetes, obesity and endocrinology. The scientific sessions include the various sessions which highlight the Diabetes types and complications, Endocrinology and metabolic syndrome, diabetic retinopathy, diabetic neuropathy, diabetic diet and nutrition, diabetes and heart disease, diabetes tests and diagnosis and prevention and treatment of diabetes.
ME Conferences welcome the delegates across the country to enlighten the young and fresh minds of the scholars, researchers, student communities and industrial delegates to attend the “31st International Diabetes and Healthcare Conference’’ with a theme “Acquainting New Insights of Diabetes & Healthcare” .
Why to attend?
This gathering will exhibit the concentrated learning on the appropriation of knowledge, opportunities to network and talk about science and medicine on diabetes and health care and the recent advances and innovations related to diabetes for the making of better health. New generation scholars and researchers will have the opportunity to explore more areas of expertise on health in diabetes. With members from all around the globe increasing the knowledge about diabetes and health care and the new advance related to diabetes. This is your best opportunity to reach the largest gathering of participants from diabetes community.
Target Audiences:
-
Diabetologists
-
Researchers
-
Endocrinologists
-
Doctors
-
Physicians
-
Nutritionists
-
Scientists
-
Academic Professionals
-
Medical Colleges and Pharma Companies
-
Medical Hospitals
-
Students
-
Business Entrepreneurs
-
Manufacture Medical Devices & Companies
-
Healthcare Training Institute
-
Oncologists
-
Neurologists
-
Pediatric doctors
-
Fitness Professionals
-
Public Health Professionals
Diabetes is a disease that occurs when blood glucose levels (blood sugar) are unusually high. The primary source of energy is blood glucose, which is derived from the foods consumed. Insulin is a hormone generated by the
pancreas that helps the cells utilise glucose from their meals. The body either does not create enough insulin or does not use it effectively all of the time. Over time, too much glucose in the blood might cause health concerns. The three most common types of diabetes are type-1 diabetes, type-2 diabetes, and gestational diabetes.
Endocrinology is concerned with the endocrine system, which consists of glands that produce hormones that regulate metabolism, growth and development, tissue function, and
reproduction. Endocrine problems are frequently divided into two groups. When a gland generates too much or too little of an endocrine hormone, it causes a hormonal imbalance. Another group is linked to the development of tumours in the endocrine system. Metabolic syndrome is a group of symptoms that, when combined, increase the risk of
heart disease, stroke, and type 2 diabetes. These disorders include high blood pressure, excessive blood sugar, extra body fat around the waist, and abnormal cholesterol. Characteristics such as age, race, obesity, and diabetes all raise the risk of metabolic syndrome.
Diabetes generates excessive blood glucose levels, which can affect the heart and blood vessels' blood arteries and nerves. The risk of heart disease and stroke is increased by smoking, high blood pressure, abnormal cholesterol levels, obesity and belly fat, and a family history of
heart disease.
High blood sugar levels are the starting point for the association between diabetes and heart disease; high glucose levels in the blood can damage arteries, causing them to stiffen and harden. Atherosclerosis is a condition in which fatty deposits accumulate in blood vessels. This can obstruct blood flow to the heart or brain, leading to a heart attack or
stroke.
The fasting plasma glucose (FPG) test is a blood test that examines blood
glucose levels in just a few seconds. For the best reliable results, do this test first thing in the morning after fasting for at least 8 hours. The A1C test is used to determine the average blood glucose levels during the past three months. Food and water can be consumed before the A1C test, and other factors like as age, anaemia, or any other blood problem will be taken into account when the A1C test is used to diagnose diabetes. The results of an A1C test are expressed as a percentage, such as A1C of 7%. The following approaches are used to diagnose diabetes:
-
Losing weight
-
Eating well
-
Exercising regularly
-
Insulin therapy
-
Blood sugar monitoring
Diabetic
neuropathy is a type of nerve damage induced by long-term high blood sugar levels. Peripheral neuropathy, autonomic neuropathy, proximal neuropathy, and localised neuropathy are all types of nerve
injury. Numbness, loss of feeling in the hands and feet, disorientation, diarrhoea, nausea, muscle weakness, loss of balance, difficulty swallowing, and indigestion are some of the symptoms. A physical examination can be used to diagnose diabetic neuropathy.
The importance of
nutrition in the treatment of diabetes patients cannot be overstated. Blood glucose levels in the patient can be regulated by eating well and in a balanced manner. For diabetics, macronutrients are the most significant dietary component. To stay healthy, patients with type 1 and type 2 diabetes must follow different nutritional diets. A low-
carbohydrate diet should be followed by diabetic people with type 1 diabetes.
When diabetes affects the
arteries, they become targets for hardening, which can result in excessive blood pressure. Diabetic people are at an increased risk of developing heart disease, stroke,
kidney failure, and other health problems. In people with diabetes, blood pressure should not exceed 130/80. Diabetic and hypertensive patients are more likely to develop cardiovascular disease. Diabetes can harm the kidneys, eyes,
neurological system, heart, and blood vessels if it is not adequately treated. People with high blood pressure and diabetes are sometimes administered blood pressure devices such ACE inhibitors, which are believed to protect the kidneys.
The pancreas recognises a constant rise in blood glucose concentration after carbs are consumed, digested, and absorbed, and produces insulin to drive an increase in glucose level in the
bloodstream, a condition known as hyperglycemia. Type 1 diabetes is caused by a significant decrease in insulin production due to beta cell death caused by autoimmunity. Type-2
diabetes is a complex condition characterised by a progressive increase in insulin resistance and a lack of insulin production, resulting in overt hyperglycemia.
Diabetic retinopathy is a condition that affects diabetic patients. It causes dynamic damage to the retina, which serves as a light-sensitive layer in the rear of the eye. Diabetic retinopathy is a hazardous condition that can cause vision abnormalities that are life-threatening. Diabetes makes it difficult for the body to use and store sugar (glucose). The condition's characteristic is an excess of sugar in the blood, which damages all parts of the body, including the
eyes.
The usage of immature cells could be extremely beneficial to diabetic patients. Research has revealed the developmental phases and transcription factors involved in the differentiation of
human embryonic undifferentiated cells into islet cells. In any case, ethical concerns as well as the potential of teratoma formation limit the use of human embryonic stem cells in clinical settings. Undifferentiated
cell therapies such as induced pluripotent stem cells, umbilical cord
stem cells, and bone marrow-derived mesenchymal undifferentiated cells have become a popular area of research in recent years. Recent advances in stem cell treatment may make this a realistic alternative for diabetes treatment.
Ethnic, social, religious, sex, and economic disparities influence access to medical treatments and the incidence of complications in patients with diabetes. The BMI cutoff for evaluating Asian Americans should be adjusted to 23 kg/m2, according to ongoing study. Women with diabetes have a 40% higher chance of getting coronary artery disease than men with diabetes. There are financial and racial inequities in the delivery of
human services to people with diabetes. As a result, children with type 1 diabetes from low-income racial/ethnic groups are more likely to have poor
metabolic control and work motivation. There are considerable racial variations and obstacles in self-checking and outcomes.
Pediatric diabetes is a disease of the endocrine organs that affects children and teenagers. It covers a wide range of topics relating to physical development and sexual enhancement in adolescents, including diabetes. Type 1 diabetes is a chronic disease in which the body's ability to process insulin responses is impaired due to the immune system's destruction of beta cells in the pancreas. Instead of exogenous
insulin resistance, the majority of diabetic children have type 1 diabetes.
Diabetes is a major risk factor for
heart disease and
stroke (CVD) (CVD). Vascular ailments include retinopathy and nephropathy, peripheral vascular infection (PVD), stroke, and coronary artery disease (CAD). Diabetes wreaks havoc on the heart muscle, causing systolic and diastolic
heart failure. It's unclear what's causing the rise in cardiovascular morbidity and mortality. Hyperglycemia, a diabetic condition, may add to heart damage after ischemia episodes, according to evidence.
The primary purpose of diabetes research is to determine the disorder's overall status. A wide range of case and research studies, including animal and human models, are available.
Type 2 diabetes is an epidemic that is quickly growing. Impaired glucose tolerance and impaired fasting
glucose are two kinds of prediabetes that arise when the body's insulin, the hormone that tells body tissues how to use glucose, is not produced. Researchers are sifting through the data to understand more about how different medicines affect the two types of prediabetes.
